33 completed. 33 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 33 | Completed 33 |
| Phase 1 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sirolimus Treatment in Pediatric Patients With Ataxia-Telangiectasia Rapamune (sirolimus/rapamycin) - Ataxia-Telangiectasia (A-T), Ataxia-Telangiectasia | Phase 2 | Completed | Sara Elva Espinosa Padilla, MD | 6 | 2024-07-11 | 2026-09-15 |
| Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) Pazopanib, Placebo oral capsule - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2 / Phase 3 | Completed | Cure HHT | 71 | 2023-05-08 | 2026-10-27 |
| Sirolimus for Nosebleeds in HHT Sirolimus - Hereditary Hemorrhagic Telangiectasia, Nosebleeds | Phase 2 | Completed | Unity Health Toronto | 10 | 2022-03-16 | 2026-06-04 |
| Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis Triheptanoin - Ataxia Telangiectasia | Phase 2 | Completed | The University of Queensland | 30 | 2022-03-15 | 2023-07-20 |
| Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT) Tacrolimus capsule (low-dose) - Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed | Phase 2 | Completed | Unity Health Toronto | 10 | 2020-10-20 | 2025-04-01 |
| Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. Nintedanib 150 mg and 100 mg soft capsules, Oral treatment of placebo soft capsule - Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease | Phase 2 | Completed | Hospices Civils de Lyon | 61 | 2020-06-22 | 2025-08-01 |
| Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia Timolol Gel, Placebo Gel - Hereditary Hemorrhagic Telangiectasia | Phase 2 | Completed | Washington University School of Medicine | 27 | 2019-10-20 | 2021-08-24 |
| Pomalidomide for the Treatment of Bleeding in HHT Pomalidomide Oral Product, Placebo oral capsule - Telangiectasia, Hereditary Hemorrhagic | Phase 2 | Completed | The Cleveland Clinic | 145 | 2019-10-17 | 2024-10-23 |
| Effects of Vitamin B3 in Patients With Ataxia Telangiectasia Vitamin B3 - Ataxia Telangiectasia, ATM Gene Mutation | Phase 2 | Completed | Radboud University Medical Center | 24 | 2019-03-18 | 2022-07-25 |
| A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) THR-317 8mg - Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia | Phase 2 | Completed | ThromboGenics | 8 | 2018-09-18 | 2020-09-02 |
| Doxycycline for Hereditary Hemorrhagic Telangiectasia Doxycycline Hyclate, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT) | Phase 2 | Completed | Unity Health Toronto | 13 | 2018-09-12 | 2025-04-01 |
| Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT) Protopic® (Tacrolimus) 0.1% ointment, Placebo - Hemorrhagic Hereditary Telangiectasia (HHT) | Phase 2 | Completed | Hospices Civils de Lyon | 50 | 2017-05-22 | 2020-07-01 |
| Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) Timolol nasal spray, Placebo nasal spray - Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease | Phase 2 | Completed | Hospices Civils de Lyon | 58 | 2015-06-01 | 2025-08-08 |
| Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose bevacuzimab spray - Telangiectasia, Hereditary Hemorrhagic | Phase 1 / Phase 2 | Completed | University Hospital, Caen | 20 | 2014-12-15 | 2026-07-30 |
| Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film Buprenorphine, Placebo film, Oxycodone - Pain | Phase 2 | Completed | BioDelivery Sciences International | 39 | 2013-06-01 | 2017-02-27 |
| Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept Topical timolol maleate, placebo saline drops - Hereditary Hemorrhagic Telangiectasia | Phase 1 / Phase 2 | Completed | Unity Health Toronto | 5 | 2013-05-01 | 2023-09-21 |
| Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. Argon Plasma Coagulation, Historical control - Radiation Injuries, Telangiectasis | Phase 2 | Completed | Barretos Cancer Hospital | 41 | 2013-01-01 | 2015-08-27 |
| Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia Thalidomide - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 2 | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 31 | 2011-11-01 | 2017-08-29 |
| North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Sterile saline, Bevacizumab, Estriol - Telangiectasia, Hereditary Hemorrhagic, Epistaxis | Phase 2 | Completed | James Gossage | 123 | 2011-08-01 | 2018-10-19 |
| Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Bevacizumab, NaCl - HHT, Morbus Osler | Phase 2 | Completed | Medical University of Vienna | 15 | 2011-03-01 | 2013-08-12 |
Showing 20 of 33. Sign in to see all of them.
Telangiectasia, Hereditary Hemorrhagic (21) · Epistaxis (11) · Ataxia Telangiectasia (5) · Retinal Telangiectasis (3) · Gastrointestinal Hemorrhage (2) · Rosacea (2) · Acne Vulgaris (1) · Anemia (1) · Angiodysplasia (1) · Arteriovenous Malformations (1) · Ataxia (1) · Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1)
Cardiovascular Diseases (33) · Vascular Diseases (33) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27) · Congenital Abnormalities (23) · Hemic and Lymphatic Diseases (23) · Hemorrhagic Disorders (23) · Hemostatic Disorders (23) · Hematologic Diseases (22) · Cardiovascular Abnormalities (21) · Vascular Malformations (20) · Pathological Conditions, Signs and Symptoms (19) · Pathologic Processes (16) · Signs and Symptoms (14) · Hemorrhage (13)
Bevacizumab (5) · Ranibizumab (2) · Sirolimus (2) · Tacrolimus (2) · Thalidomide (2) · Argon Plasma Coagulation (1) · Buprenorphine (1) · Capsules (1) · Caspofungin (1) · Cellulose (1) · Doxycycline (1) · Estriol (1) · Estrogens (1) · Historically Controlled Study (1) · Lasers, Gas (1)
Hospices Civils de Lyon (4) · Unity Health Toronto (4) · Manhattan Eye, Ear & Throat Hospital (2) · University of California, San Diego (2) · Barretos Cancer Hospital (1) · BioDelivery Sciences International (1) · Cure HHT (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Eye Center of Northern Colorado, P.C. (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · James Gossage (1) · Julian M. Mackay-Wiggan (1) · Medical University of Vienna (1) · National Center for Research Resources (NCRR) (1) · Northport Veterans Affairs Medical Center (1)
United States (14) · France (7) · Canada (4) · Italy (2) · Switzerland (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Germany (1) · Israel (1) · Mexico (1) · Netherlands (1) · Slovakia (1) · Turkey (Türkiye) (1)
Marie E Faughnan, MD MSc FRCPC (3) · James Gossage, MD (2) · Lawrence A. Yannuzzi, MD (2) · Arthur Korotkin, M.D. (1) · Atul Kumar, MD (1) · Carlo Balduini, M.D. (1) · Claudio Viscoli, MD (1) · David Coman, MBBS FRACP (1) · Eitan Yaniv, MD (1) · Gerald D Weinstein, MD (1) · Holly Boyer, MD (1) · James R Gossage, MD (1) · Jay F Piccirillo, MD (1)
PMID 16763896, PMID 16934683, PMID 19841031, PMID 22144182, PMID 22396517, PMID 22875082, PMID 22927201, PMID 24236946, PMID 24595923, PMID 25656498, PMID 26433381, PMID 26547562, PMID 26686256, PMID 26851119, PMID 27599329, PMID 28871440, PMID 28969699, PMID 29110179, PMID 30191360, PMID 30586396, PMID 30796268, PMID 30948626, PMID 31427745, PMID 32940653, PMID 33437944, PMID 36344987, PMID 39292928, PMID 39510938, PMID 39718659, PMID 41719457
2017 (2), 2009 (1), 2015 (1), 2019 (1), U54NS065705 (1)